Non-Hodgkin Lymphoma
Biovest files for regulatory approval of BiovaxID
Published in Biotech Business Week, July 3rd, 2006
The opening of these sites is expected to dramatically increase the number of patients being treated with BiovaxID during the next 12 to 18 months. The filings have been submitted by the contract research organizations, which will manage the trials for Biovest in Ukraine and Russia and will be responsible for monitoring patient recruitment and overseeing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Healthcare Coverage
Survey shows employers unaware of rising radiology costs, savings opportunity - Imaging
New generation of diagnostic imaging agents raising expectations and expanding applications - Market Analysis
Biotech takes it on the chin in May - Market Analysis
New report released on emerging issues in target-based drug discovery - Market Analysis
Spending on biotech drugs to treat inflammatory diseases up 33.9% in 2005, report says - Acute Lymphoblastic Leukemia
Bioenvision receives European approval for Evoltra - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
